These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 26826008)
21. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration. Rais R; Wozniak K; Wu Y; Niwa M; Stathis M; Alt J; Giroux M; Sawa A; Rojas C; Slusher BS PLoS One; 2015; 10(7):e0131861. PubMed ID: 26151906 [TBL] [Abstract][Full Text] [Related]
22. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA). Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700 [TBL] [Abstract][Full Text] [Related]
24. GCPII Inhibition Promotes Remyelination after Peripheral Nerve Injury in Aged Mice. Su Y; Huang M; Thomas AG; Maragakis J; Huizar KDJ; Zheng Y; Wu Y; Farah MH; Slusher BS Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000003 [TBL] [Abstract][Full Text] [Related]
25. Altered cognitive-emotional behavior in early experimental autoimmune encephalitis--cytokine and hormonal correlates. Acharjee S; Nayani N; Tsutsui M; Hill MN; Ousman SS; Pittman QJ Brain Behav Immun; 2013 Oct; 33():164-72. PubMed ID: 23886782 [TBL] [Abstract][Full Text] [Related]
26. Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes. Tiffany CW; Cai NS; Rojas C; Slusher BS Eur J Pharmacol; 2001 Sep; 427(2):91-6. PubMed ID: 11557259 [TBL] [Abstract][Full Text] [Related]
27. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia. Baslow MH; Dyakin VV; Nowak KL; Hungund BL; Guilfoyle DN J Mol Neurosci; 2005; 26(1):1-15. PubMed ID: 15968081 [TBL] [Abstract][Full Text] [Related]
28. Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay. Rojas C; Frazier ST; Flanary J; Slusher BS Anal Biochem; 2002 Nov; 310(1):50-4. PubMed ID: 12413472 [TBL] [Abstract][Full Text] [Related]
29. Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay. Tallarida C; Song K; Raffa RB; Rawls SM Amino Acids; 2012 Jun; 42(6):2521-4. PubMed ID: 21850438 [TBL] [Abstract][Full Text] [Related]
30. Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis. Dayger CA; Rosenberg JS; Winkler C; Foster S; Witkowski E; Benice TS; Sherman LS; Raber J Pharmacol Biochem Behav; 2013 Feb; 103(4):860-8. PubMed ID: 23201649 [TBL] [Abstract][Full Text] [Related]
31. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392 [TBL] [Abstract][Full Text] [Related]
32. Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone. Kwilasz AJ; Todd LS; Duran-Malle JC; Schrama AEW; Mitten EH; Larson TA; Clements MA; Harris KM; Litwiler ST; Wang X; Van Dam AM; Maier SF; Rice KC; Watkins LR; Barrientos RM Behav Brain Res; 2021 Jan; 396():112896. PubMed ID: 32905811 [TBL] [Abstract][Full Text] [Related]
33. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents. Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864 [TBL] [Abstract][Full Text] [Related]
34. Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis. LoPresti P Neurochem Res; 2015 Mar; 40(3):473-9. PubMed ID: 25481047 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats. Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261 [TBL] [Abstract][Full Text] [Related]
36. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis. Zagon IS; Rahn KA; Turel AP; McLaughlin PJ Exp Biol Med (Maywood); 2009 Nov; 234(11):1383-92. PubMed ID: 19855075 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice. Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142 [TBL] [Abstract][Full Text] [Related]
39. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications. Neale JH; Yamamoto T Prog Neurobiol; 2020 Jan; 184():101722. PubMed ID: 31730793 [TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate. Aharoni R; Schottlender N; Bar-Lev DD; Eilam R; Sela M; Tsoory M; Arnon R Sci Rep; 2019 Mar; 9(1):4140. PubMed ID: 30858445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]